Finding the Appropriate Therapeutic Strategy in Patients with Neuroendocrine Tumors of the Pancreas: Guideline Recommendations Meet the Clinical Reality

The systemic treatment of patients with pancreatic neuroendocrine tumors is based on placebo-controlled trials and long-established chemotherapy approaches. In addition, peptide receptor radionuclide therapy (PRRT) was approved as a parallel approach for pancreatic neuroendocrine tumors (NET), in ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Krug, Sebastian, Damm, Marko, Garbe, Jakob, König, Senta, Schmitz, Rosa Lynn, Michl, Patrick, Schrader, Jörg, Rinke, Anja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304907/
https://www.ncbi.nlm.nih.gov/pubmed/34300189
http://dx.doi.org/10.3390/jcm10143023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304907/
https://www.ncbi.nlm.nih.gov/pubmed/34300189
http://dx.doi.org/10.3390/jcm10143023

Ejemplares similares